Elevated Microsatellite Alterations at Selected Tetranucleotides (EMAST) in Colorectal Cancer is Associated with an Elderly, Frail Phenotype and Improved Recurrence-Free Survival-Reference-Cited by-同舟云学术

Elevated Microsatellite Alterations at Selected Tetranucleotides (EMAST) in Colorectal Cancer is Associated with an Elderly, Frail Phenotype and Improved Recurrence-Free Survival

Published:2019-11-04 Issue:4 Volume:27 Page:1058-1067
ISSN:1068-9265
Container-title:Annals of Surgical Oncology
language:en
Short-container-title:Ann Surg Oncol

Author:

Watson Martin M.,Kanani Arezo,Lea Dordi,Khajavi Ramesh B.,Søreide Jon Arne,Kørner Hartwig,Hagland Hanne R.,Søreide Kjetil^ORCID

Funder

University of Stavanger

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Surgery

Link

http://link.springer.com/content/pdf/10.1245/s10434-019-08048-6.pdf

Reference39 articles.

1. Boland CR, Goel A. Microsatellite instability in colorectal cancer. Gastroenterology. 2010;138(6):2073–87.e3.

2. Umar A, Boland CR, Terdiman JP, et al. Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Ins. 2004;96(4):261–8.

3. Drake TM, Soreide K. Cancer epigenetics in solid organ tumours: A primer for surgical oncologists. Eur J Surg Oncol. 2019;45(5):736–46.

4. Sinicrope FA. Lynch syndrome—associated colorectal cancer. N Engl J Med. 2018;379(8):764–73.

5. Gupta R, Sinha S, Paul RN. The impact of microsatellite stability status in colorectal cancer. Curr Probl Cancer. 2018;42(6):548–59.

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Programmed death ligand-1 (PD-L1) clone 22C3 expression in resected colorectal cancer as companion diagnostics for immune checkpoint inhibitor therapy: A comparison study and inter-rater agreement evaluation across proposed cut-offs and predictive (TPS, CPS and IC) scores;Cancer Treatment and Research Communications;2024

2. Clinical trials of neoadjuvant immune checkpoint inhibitors for early-stage operable colon and rectal cancer;Cancer Immunology, Immunotherapy;2023-08-01

3. Precision Medicine in the Era of Genetic Testing: Microsatellite Instability Evolved;Clinics in Colon and Rectal Surgery;2023-07-25

4. Neoadjuvant immunotherapy in colorectal cancer beyond immune checkpoint inhibitors: emerging from bench to bedside;Minerva Surgery;2023-07

5. Potential for companion diagnostic use and inter-rater agreement of programmed death ligand-1 (PD-L1) clone 22C3 expression scores in colorectal cancer;2023-04-18